Theoretical Arguments and Trials of Vasopressin as a Vasopressor in ICU

Exploring the potential advantages of vasopressin as a vasopressor in ICU patients, including its effectiveness in the presence of metabolic acidosis and its impact on pulmonary arterial constriction. Mention of the Vastral VA SST trial as a significant study on vasopressin use in septic patients.